Equities

Neuroone Medical Technologies Corp

NMTC:NAQ

Neuroone Medical Technologies Corp

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (USD)0.89
  • Today's Change-0.01 / -1.11%
  • Shares traded21.23k
  • 1 Year change-32.58%
  • Beta0.7663
Data delayed at least 15 minutes, as of Nov 12 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Neuroone Medical Technologies Corp fell by 2.84m. Cash Flow from Financing totalled 7.40m or 214.57% of revenues. In addition the company used 12.89m for operations while cash from investing totalled 2.65m.
Cash flow per share-0.4766
Price/Cash flow per share--
Book value per share0.1082
Tangible book value per share0.1055
More ▼

Balance sheet in USDView more

Neuroone Medical Technologies Corp has little financial risk as the capital structure does not rely on leverage.
Current ratio2.42
Quick ratio1.36
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.